VCIM
TIL icon

Velan Capital Investment Management’s Instil Bio TIL Stock Holding History

Velan Capital Investment Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69,000
Closed -$1.2M – 57
2025
Q1 		$1.2M Buy
+69,000
New +$1.43M 1.23% 16

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Velan Capital Investment Management's TIL Position: Q2 2025 in Review

Velan Capital Investment Management sold out of Instil Bio (TIL) in Q2 2025, closing a stake of 69,000 shares — an estimated $1.2M sold.

Velan Capital Investment Management first reported a position in TIL in Q1 2025 and held it in 1 quarter. The position peaked at $1.2M in Q1 2025. 38 funds tracked by Wall St. Rank hold TIL as of Q2 2025.

  • Velan Capital Investment Management reported no remaining Instil Bio position as of Q2 2025 after selling out during the quarter.
  • Velan Capital Investment Management sold 69,000 Instil Bio shares in Q2 2025, an estimated $1.2M.
  • Velan Capital Investment Management first reported a position in Instil Bio in Q1 2025 and held it in 1 quarter.
  • Velan Capital Investment Management's Instil Bio position peaked at $1.2M in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Instil Bio as of Q2 2025.

Based on Velan Capital Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.